Last day to apply for pandemic relief grants in Ventura County; Guadalupe offers startup assistance
The application window for Ventura County’s COVID-19 assistance grant program to help businesses and nonprofit organizations will close at 6 p.m. on Sept. 2. Ventura County launched its fourth COVID-19 assistance grant program for businesses and nonprofits that did not receive a grant during the county’s prior business programs. Ventura County-based businesses and nonprofits may Read More →
Semtech shares up after strong earnings report
Semtech Corp., a Camarillo semiconductor company specializing in Internet of Things applications, saw shares up more than 5% after the markets closed Sept. 1 after the company shared a record-breaking financial statement for the second quarter of fiscal year 2021-22. Semtech delivered earnings of $32.2 million, or 50 cents per share, for the second quarter Read More →
QAD reports loss as $2B acquisition nears
QAD, a Santa Barbara-based cloud software company for the manufacturing industry, saw its revenue and expenses rise in the second quarter of 2021 as the company prepares to be bought out by a San Francisco-based private equity firm. QAD lost $6.3 million, or 31 cents per share, in the quarter ended July 31, the company Read More →
Teledyne Chairman Mehrabian will step back into CEO’s office
Teledyne Technologies Chairman Robert Mehrabian, who spent two decades as the company’s CEO, will step back into that post when Teledyne’s current CEO, Al Pichelli, retires on Oct. 15. Mehrabian is Pichelli’s predecessor as well as his successor — Pichelli took over as CEO on Jan. 1, 2019 when Mehrabian stepped down. Mehrabian was president Read More →
In Ventura, Nexa3D prints the future of manufacturing
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Arcutis starts new Phase 3 trial
Arcutis Biotherapeutics announced Aug. 25 that it has enrolled the first patient in a Phase 3 clinical trial to evaluate ARQ-154, its topical foam, as a treatment for scalp and body psoriasis. The foam is a once-daily formulation of roflumilast, a phosphodiesterase type 4 inhibitor that the company is developing to treat two skin conditions: Read More →
Ventura County takes new tack to redevelop Channel Islands Harbor
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
